Generalized hypertrichosis due to secukinumab in a patient with moderate psoriasis: A case of serendipity or zemblanity?

Aged Alopecia Areata / chemically induced Antibodies, Monoclonal, Humanized / adverse effects Humans Hypertrichosis / chemically induced Male Psoriasis / drug therapy
alopecia areata anti-IL17 drug adverse events hypertrichosis psoriasis

Journal

Dermatologic therapy
ISSN: 1529-8019
Titre abrégé: Dermatol Ther
Pays: United States
ID NLM: 9700070

Informations de publication

Date de publication:
05 2019
Historique:
received: 23 11 2018
accepted: 05 04 2019
pubmed: 10 4 2019
medline: 28 1 2020
entrez: 10 4 2019
Statut: ppublish

Résumé

After 4 months of therapy with secukinumab, a 67-year-old man with moderate psoriasis developed generalized hypertrichosis, along with PASI 90. The patient denied any drug intake, apart from secukinumab, nor applications of any creams. Moreover, this event did not really bother the patient, thus the therapy was not discontinued and the hypertrichosis is persisting as psoriasis' control.

Identifiants

DOI: 10.1111/dth.12894 PMID: 30963671
pubmed: 30963671
doi: 10.1111/dth.12894
doi:

Substances chimiques

Antibodies, Monoclonal, Humanized 0
secukinumab DLG4EML025

Types de publication

Case Reports Letter

Langues

eng

Sous-ensembles de citation

IM

Pagination

e12894

Informations de copyright

© 2019 Wiley Periodicals, Inc.

Auteurs

Lidia Sacchelli (L)

Division of Dermatology, Department of Specialized, Clinical and Experimental Medicine, University of Bologna, Bologna, Italy.
ORCID: 0000-0003-4388-4523

Michela Magnano (M)

Division of Dermatology, Department of Specialized, Clinical and Experimental Medicine, University of Bologna, Bologna, Italy.
ORCID: 0000-0001-9429-9004

Annalisa Patrizi (A)

Division of Dermatology, Department of Specialized, Clinical and Experimental Medicine, University of Bologna, Bologna, Italy.

Federico Bardazzi (F)

Division of Dermatology, Department of Specialized, Clinical and Experimental Medicine, University of Bologna, Bologna, Italy.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Sujet âgé › Generalized hypertrichosis due to secukinumab...
questionsmedicales.fr › Maladies de la peau et du tissu conjonctif › Maladies de la peau › Maladies du système pileux › Hypotrichose › Pelade › Generalized hypertrichosis due to secukinumab...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Globulines › Sérum-globulines › Immunoglobulines › Anticorps › Anticorps monoclonaux › Anticorps monoclonaux humanisés › Generalized hypertrichosis due to secukinumab...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Generalized hypertrichosis due to secukinumab...
questionsmedicales.fr › Maladies de la peau et du tissu conjonctif › Maladies de la peau › Maladies du système pileux › Hypertrichose › Generalized hypertrichosis due to secukinumab...
questionsmedicales.fr › Maladies de la peau et du tissu conjonctif › Maladies de la peau › Dermatoses papulosquameuses › Psoriasis › Generalized hypertrichosis due to secukinumab...